ロード中...
StrandAdvantage test for early‐line and advanced‐stage treatment decisions in solid tumors
Comprehensive genetic profiling of tumors using next‐generation sequencing (NGS) is gaining acceptance for guiding treatment decisions in cancer care. We designed a cancer profiling test combining both deep sequencing and immunohistochemistry (IHC) of relevant cancer targets to aid therapy choices i...
保存先:
| 出版年: | Cancer Med |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2017
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5430095/ https://ncbi.nlm.nih.gov/pubmed/28371134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1037 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|